RAK pharmaceutical company was platinum sponsor of event
Showcased new erectile dysfunction product
Ras Al Khaimah, United Arab Emirates -Monday, December
Julphar (Gulf Pharmaceutical Industries), the largest generic pharmaceutical manufacturer in the MENA region, marked its entry into the men’s health sector with the launch of a new erectile dysfunction product, Dandasha (Tadalafil 20 mg), at the first Men’s Health Congress.
Julphar participated as
The RAK-based pharmaceutical company later hosted an event to showcase Dandasha at the One&Only Royal Mirage Dubai, which was attended by His Highness Sheikh Faisal Bin Saqr Al Qasimi, Chairman of Julphar, as well as more than 300 healthcare professionals.
Commenting on the launch,
“At Julphar, we are committed to improving the quality of life of our patients, while ensuring the quality, safety
Dandasha (Tadalafil 20 mg) is sold in tablet form and is an inhibitor of phosphodiesterase type 5 (PDE5), which mediates relaxation of vascular smooth muscle in particular areas of the body, facilitating and maintaining
Lama Mohanna, Communication Coordinator
M +971501740731, T +97172461461, D +97172045722
Permalink : http://aetoswire.com/news/5234/en